Evusheld and the PBS

18 October 2022

On 14 October 2022, the Pharmaceutical Benefits Advisory Committee (PBAC) recommended that Evusheld not be listed on the Pharmaceutical Benefits Scheme (PBS). However, this may be revised in the future and access will remain through current schemes.

For more information on this announcement click here | For information about Evusheld click here


Contact the team at MSWA if you have any related questions.